PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Synergistic cytotoxicity of HDAC and PARP inhibitors and decitabine in pancreatic cancer cells: implications for novel therapy

Synergistic cytotoxicity of HDAC and PARP inhibitors and decitabine in pancreatic cancer cells: implications for novel therapy
2024-06-05
(Press-News.org)

“The results provide novel preclinical data that demonstrate synergism between HDACi- and PARPi-mediated inhibition of DNA repair and decitabine in pancreatic cancer [...]”

BUFFALO, NY- June 5, 2024 – A new research paper was published in Oncotarget's Volume 15 on June 3, 2024, entitled, “Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy.”

Histone deacetylase inhibitors (HDACi) can modulate the acetylation status of proteins, influencing the genomic instability exhibited by cancer cells. Poly (ADP ribose) polymerase (PARP) inhibitors (PARPi) have a direct effect on protein poly (ADP-ribosyl)ation, which is important for DNA repair. Decitabine is a nucleoside cytidine analogue, which when phosphorylated gets incorporated into the growing DNA strand, inhibiting methylation and inducing DNA damage by inactivating and trapping DNA methyltransferase on the DNA, thereby activating transcriptionally silenced DNA loci.

In this new study, researchers Benigno C. Valdez, Apostolia M. Tsimberidou, Bin Yuan, Yago Nieto, Mehmet A. Baysal, Abhijit Chakraborty, Clark R. Andersen, and Borje S. Andersson from The University of Texas MD Anderson Cancer Center explored various combinations of HDACi and PARPi +/− decitabine (hypomethylating agent) in pancreatic cancer cell lines BxPC-3 and PL45 (wild-type BRCA1 and BRCA2) and Capan-1 (mutated BRCA2). 

“[...] we explored various combinations of HDACis and PARPis, with or without decitabine, in pancreatic cancer cell lines.”

The combination of HDACi (panobinostat or vorinostat) with PARPi (talazoparib or olaparib) resulted in synergistic cytotoxicity in all cell lines tested. The addition of decitabine further increased the synergistic cytotoxicity noted with HDACi and PARPi, triggering apoptosis (evidenced by increased cleavage of caspase 3 and PARP1). 

The 3-drug combination treatments (vorinostat, talazoparib, and decitabine; vorinostat, olaparib, and decitabine; panobinostat, talazoparib, and decitabine; panobinostat, olaparib, and decitabine) induced more DNA damage (increased phosphorylation of histone 2AX) than the individual drugs and impaired the DNA repair pathways (decreased levels of ATM, BRCA1, and ATRX proteins). The 3-drug combinations also altered the epigenetic regulation of gene expression (NuRD complex subunits, reduced levels). 

“This is the first study to demonstrate synergistic interactions between the aforementioned agents in pancreatic cancer cell lines and provides preclinical data to design individualized therapeutic approaches with the potential to improve pancreatic cancer treatment outcomes.”

 

Continue reading: DOI: https://doi.org/10.18632/oncotarget.28588 

Correspondence to: Apostolia M. Tsimberidou

Email: atsimber@mdanderson.org 

Keywords: decitabine, HDAC inhibitors, pancreatic cancer, PARP inhibitors, synergistic cytotoxicity

Click here to sign up for free Altmetric alerts about this article.
 

About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:

X, formerly Twitter Facebook YouTube Instagram LinkedIn Pinterest Reddit Spotify, and available wherever you listen to podcasts

 

Click here to subscribe to Oncotarget publication updates.

For media inquiries, please contact media@impactjournals.com.

 

Oncotarget Journal Office

6666 East Quaker Street., Suite 1A

Orchard Park, NY 14127

Phone: 1-800-922-0957 (option 2)

###

END


[Attachments] See images for this press release:
Synergistic cytotoxicity of HDAC and PARP inhibitors and decitabine in pancreatic cancer cells: implications for novel therapy Synergistic cytotoxicity of HDAC and PARP inhibitors and decitabine in pancreatic cancer cells: implications for novel therapy 2 Synergistic cytotoxicity of HDAC and PARP inhibitors and decitabine in pancreatic cancer cells: implications for novel therapy 3

ELSE PRESS RELEASES FROM THIS DATE:

UBC-developed oral insulin drops offer relief for diabetes patients

UBC-developed oral insulin drops offer relief for diabetes patients
2024-06-05
Diabetes rates continue to rise, with 11.7 million Canadians living with diabetes or pre-diabetes. At UBC, scientists have created a pain-free drug delivery method to help people with diabetes manage the disease and maintain their health more easily. Researchers at the Li Lab have developed oral insulin drops that when placed under the tongue are quickly and efficiently absorbed by the body, potentially replacing the need for insulin injections. The drops contain a mixture of insulin and a unique cell-penetrating peptide (CPP) developed ...

Could taking certain drugs reduce risk of ruptured brain aneurysm?

2024-06-05
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, JUNE 5, 2024 MINNEAPOLIS – A new study suggests that people who take a few common drugs may have a decreased risk of having a bleeding stroke due to a ruptured brain aneurysm. The study is published in the June 5, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The results do not prove that these drugs reduce the risk of this type of aneurysm; they only show an association. “We urgently need new ways to prevent this type of stroke, which occurs at younger ages and with a higher death rate than other types of stroke,” said study author Jos Peter Kanning, ...

Fellowships will advance reporters’ coverage of aging in America

2024-06-05
The Gerontological Society of America (GSA) has received renewed grant support to welcome a 15th class of reporters for the Journalists in Aging Fellows Program. The 2024 funders to date include Silver Century Foundation, The John A. Hartford Foundation, and National Institute for Health Care Management Foundation (NIHCM). Since its founding in 2010, this program has been responsible for more than 800 news stories produced by 231 alumni. It has two goals: to educate journalists about issues in aging, better allowing them to spread a new awareness to general-audience, ethnic, and other minority populations; and to disseminate information about new scientific findings, ...

Study shows AI-driven cyberattacks can inflict damage on GDP and supply chains for the world’s largest economies

2024-06-05
Cyberattacks driven by Artificial Intelligence (AI) pose unprecedented risks to global economies, supply chains, and trade. A forthcoming study from the journal Risk Analysis explores the cascading impacts of AI-driven cyberattacks. Unlike traditional cyberattacks, which are typically manual or scripted, AI-driven cyberattacks utilize AI and machine learning algorithms to enhance their effectiveness, stealthiness and adaptability. AI-driven cyberattacks can autonomously learn and evolve their tactics, techniques and procedures based on real-time feedback and environmental changes. Through simulation scenarios, the researchers discovered the potential ...

Allison Institute announces appointment of two immunobiology experts as associate members

Allison Institute announces appointment of two immunobiology experts as associate members
2024-06-05
HOUSTON ― The James P. Allison Institute at The University of Texas MD Anderson Cancer Center today announced the appointment of its newest members, Susan Bullman, Ph.D., and Xi Chen, Ph.D., to further the institute’s ongoing work of impactful immunobiology research. These accomplished researchers, joining as associate members, bring valuable expertise in studying how the intratumoral microbiome and the immune microenvironment influence patient responses to immunotherapy. As Allison Institute members, Bullman and Chen will lead impactful research programs aligned with the institute’s ...

Focused Ultrasound Foundation designates Virginia Tech as a Center of Excellence

Focused Ultrasound Foundation designates Virginia Tech as a Center of Excellence
2024-06-05
The Focused Ultrasound Foundation has designated Virginia Tech as a Focused Ultrasound (FUS) Center of Excellence, making it the sixth such center in the United States and one of only 12 in the world. “Virginia Tech possesses significant strengths in the FUS field, and it is an honor to recognize them as a Center of Excellence,” said Neal F. Kassell, founder and chairman of the Focused Ultrasound Foundation. “With distinguished experts across the colleges of engineering, science, veterinary medicine, and medicine, ...

US public opinion on social media is warming to nuclear energy, but concerns remain

2024-06-05
Images The U.S. public displays more positive than negative sentiment toward nuclear energy but concerns remain about waste, cost and safety, according to an analysis of 300,000 posts on X (formerly Twitter) by University of Michigan researchers.    The study was recently published in Renewable and Sustainable Energy Reviews.   Identifying public concerns and misconceptions about nuclear energy can target efforts to bridge these gaps as nuclear energy will play a large role in goals to decarbonize ...

Flapping frequency of birds, insects, bats and whales described by universal equation

Flapping frequency of birds, insects, bats and whales described by universal equation
2024-06-05
A single universal equation can closely approximate the frequency of wingbeats and fin strokes made by birds, insects, bats and whales, despite their different body sizes and wing shapes, Jens Højgaard Jensen and colleagues from Roskilde University in Denmark report in a new study in the open-access journal PLOS ONE, publishing June 5. The ability to fly has evolved independently in many different animal groups. To minimize the energy required to fly, biologists expect that the frequency that animals flap their wings should be determined by the natural resonance frequency of the wing. However, finding a universal mathematical description of flapping flight has proved ...

Pro-inflammatory diets are associated with higher levels of the heart failure biomarker NT-proBNP, with potential implications for cardiovascular risk, per study of more than 10,000 US adults

2024-06-05
Pro-inflammatory diets are associated with higher levels of the heart failure biomarker NT-proBNP, with potential implications for cardiovascular risk, per study of more than 10,000 US adults ### Article URL:  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0304289 Article Title: Association between dietary inflammatory index and NT-proBNP levels in US adults: A cross-sectional analysis Author Countries: China Funding: The study was funded by the Yan'an Science and Technology Plan Project (Grant No. 2022SLSFGG-025).The funders ...

Normal ageing might be associated with increased blood-brain barrier permeability in regions also vulnerable in Alzheimer's Disease, in small study comparing healthy brains of the young and old

Normal ageing might be associated with increased blood-brain barrier permeability in regions also vulnerable in Alzheimers Disease, in small study comparing healthy brains of the young and old
2024-06-05
Normal ageing might be associated with increased blood-brain barrier permeability in regions also vulnerable in Alzheimer's Disease, in small study comparing healthy brains of the young and old ### Article URL:  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0299764 Article Title: Associations between regional blood-brain barrier permeability, aging, and Alzheimer’s disease biomarkers in cognitively normal older adults Author Countries: USA Funding: Research reported in this publication was supported ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Synergistic cytotoxicity of HDAC and PARP inhibitors and decitabine in pancreatic cancer cells: implications for novel therapy